PERFORMANCE STANDARDS FOR REVIEW OF CLASS III DEVICES WOULD BE ADOPTED WITHIN ONE YEAR OF ENACTMENT OF MEASURE INTRODUCED BY SEN. WELLSTONE OCT. 31
This article was originally published in The Gray Sheet
Executive Summary
FDA would be directed to adopt performance standards to aid in the review of Class III devices within one year of enactment of an FDA device reform bill (S 1369) introduced Oct. 31 by Sen. Paul Wellstone (D-Minn.). The "Medical Technology, Public Health, and Innovation Act of 1995" calls on the agency, within 365 days of the measure's enactment, to adopt "performance standards established by nationally and internationally recognized standard-setting entities and use the standards when applicable to assist in determining the safety and effectiveness of Class III devices."
You may also be interested in...
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.